Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

CODEX DNA, INC.

(DNAY)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

Codex DNA : Taps CleanCap mRNA Capping Technology From Maravai LifeSciences Unit TriLink

07/21/2021 | 10:26am EDT


ę MT Newswires 2021
All news about CODEX DNA, INC.
09/20CODEX DNA, INC.(NASDAQGS : DNAY) added to S&P TMI Index
CI
09/16CODEX DNA : Departure of Directors or Certain Officers; Election of Directors; Appointment..
PU
09/16CODEX DNA, INC. : Change in Directors or Principal Officers (form 8-K)
AQ
09/16Codex DNA, Inc. Announces Departure of Timothy E. Cloutier as Senior Vice President, Ef..
CI
09/01Codex Dna Releases Full-Length Synthetic Genome for Highly Infectious Sars-Cov-2 Delta ..
CI
08/11CODEX DNA : Management's discussion and analysis of financial condition and results of ope..
AQ
08/10CODEX DNA : Reports Second Quarter 2021 Financial Results (Form 8-K)
PU
08/10CODEX DNA, INC. : Results of Operations and Financial Condition, Financial Statements and ..
AQ
08/10CODEX DNA : Earnings Flash (DNAY) CODEX DNA Reports Q2 Revenue $2.9M, vs. Street Est of $2..
MT
08/10CODEX DNA : Reports Second Quarter 2021 Financial Results
AQ
More news
Analyst Recommendations on CODEX DNA, INC.
More recommendations
Financials (USD)
Sales 2021 12,5 M - -
Net income 2021 -32,8 M - -
Net Debt 2021 - - -
P/E ratio 2021 -8,98x
Yield 2021 -
Capitalization 318 M 318 M -
Capi. / Sales 2021 25,5x
Capi. / Sales 2022 15,4x
Nbr of Employees 108
Free-Float 47,3%
Chart CODEX DNA, INC.
Duration : Period :
Codex DNA, Inc. Technical Analysis Chart | DNAY | US1920031010 | MarketScreener
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 3
Last Close Price 10,87 $
Average target price 26,50 $
Spread / Average Target 144%
EPS Revisions
Managers and Directors
Todd R. Nelson President, Chief Executive Officer & Director
Jennifer Isacoff McNealey Chief Financial Officer
Daniel G. Gibson Chief Technology Officer
Justin O. Emory Vice President-Information Technology
Franklin R. Witney Independent Director
Sector and Competitors